FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stevo Julius

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Anatomy

Sympathetic Nervous System

Procedures

Double-Blind Method

Co-author Network

Publications

TOP 3
Stevo Julius; Niko A Kaciroti; Suzanne Oparil
Reply to Visit-to-visit blood pressure variation: time to reanalyze all the data from the TROPHY study.
Emily B Levitan; Stevo Julius; Niko A Kaciroti; Suzanne Oparil; Paul Muntner
Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure.
Michael A Weber; Dion H Zappe; Hans R Brunner; Tsushung A Hua; Yan Jia; Stevo Julius; Sverre E Kjeldsen; Giuseppe Mancia; Gordon T McInnes; Anthony Schork; Alberto Zanchetti
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stevo Julius (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stevo Julius; Niko A Kaciroti; Suzanne Oparil
Reply to Visit-to-visit blood pressure variation: time to reanalyze all the data from the TROPHY study.
Journal of clinical hypertension (Greenwich, Conn.) 2013;15(4):301.
2012: Emily B Levitan; Stevo Julius; Niko A Kaciroti; Suzanne Oparil; Paul Muntner
Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(11):744-50.
2012: Michael A Weber; Dion H Zappe; Hans R Brunner; Tsushung A Hua; Yan Jia; Stevo Julius; Sverre E Kjeldsen; Giuseppe Mancia; Gordon T McInnes; Anthony Schork; Alberto Zanchetti
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
Journal of hypertension 2012;30(11):2213-22.
2012: Niko A Kaciroti; Trivellore E Raghunathan; Jeremy M G Taylor; Stevo Julius
A Bayesian model for time-to-event data with informative censoring.
Biostatistics (Oxford, England) 2012;13(2):341-54.
2012: Peter M Okin; Björn Dahlöf; Stevo Julius; Sverre E Kjeldsen; Richard B Devereux
Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study.
Heart rhythm : the official journal of the Heart Rhythm Society 2012;9(4):531-7.
2012: Stevo Julius; Sverre E Kjeldsen; Hans R Brunner; Bjoern Holzhauer; Tsushung A Hua; Kenneth A Jamerson; Silja Majahalme; Giuseppe Mancia; Gordon T McInnes; Paolo Palatini; M Anthony Schork; Michael A Weber; Alberto Zanchetti; Dion Zappe; Nevrez Koylan
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.
The American journal of cardiology 2012;109(5):685-92.
2012: Peter M Okin; Björn Dahlöf; Darcy A Hille; Stevo Julius; Sverre E Kjeldsen; Richard B Devereux
Effect of changing heart rate during treatment of hypertension on incidence of heart failure.
The American journal of cardiology 2012;109(5):699-704.
2010: Carlos Feldstein; Stevo Julius
Establishing targets for hypertension control in patients with comorbidities.
Current hypertension reports 2010;12(6):465-73.
2010: Stevo Julius; Sverre E Kjeldsen; Michael A Weber
Angiotensin-receptor blockade, cancer, and concerns.
The lancet oncology 2010;11(9):820-1; author reply 821-2.
2010: Peter M Okin; Sverre E Kjeldsen; Stevo Julius; Darcy A Hille; Björn Dahlöf; Jonathan M Edelman; Richard B Devereux
All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy.
European heart journal 2010;31(18):2271-9.
2009: Carlos A Feldstein; Stevo Julius
The complex interaction between overweight, hypertension, and sympathetic overactivity.
Journal of the American Society of Hypertension : JASH 2009;3(6):353-65.
2009: Stevo Julius
Tachycardia in hypertension: a saga of progress despite prejudice, confusion, and inertia.
Progress in cardiovascular diseases 2009;52(1):26-30.
2009: Paolo Palatini; Stevo Julius
The role of cardiac autonomic function in hypertension and cardiovascular disease.
Current hypertension reports 2009;11(3):199-205.
2009: Stevo Julius
Prehypertension in China.
Journal of hypertension 2009;27(4):700-1.
2009: Niko A Kaciroti; M Anthony Schork; Trivellore E Raghunathan; Stevo Julius
A Bayesian sensitivity model for intention-to-treat analysis on binary outcomes with dropouts.
Statistics in medicine 2009;28(4):572-85.
2009: Sverre E Kjeldsen; Richard B Devereux; Darcy A Hille; Paulette A Lyle; Björn Dahlöf; Stevo Julius; Jonathan M Edelman; Steven M Snapinn; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study.
Blood pressure 2009;18(6):348-61.
2008: Peter M Okin; Kristian Wachtell; Sverre E Kjeldsen; Stevo Julius; Lars H Lindholm; Björn Dahlöf; Darcy A Hille; Markku S Nieminen; Jonathan M Edelman; Richard B Devereux
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Circulation. Arrhythmia and electrophysiology 2008;1(5):337-43.
2008: Hiroyuki Sasamura; Hideaki Nakaya; Stevo Julius; Toru Takebayashi; Yuji Sato; Hajime Uno; Masahiro Takeuchi; Kimiko Ishiguro; Marohito Murakami; Munekazu Ryuzaki; Hiroshi Itoh
The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study design.
Hypertension research : official journal of the Japanese Society of Hypertension 2008;31(10):1843-9.
2008: Brent M Egan; Stevo Julius
Prehypertension: risk stratification and management considerations.
Current hypertension reports 2008;10(5):359-66.
2008: Brent M Egan; Shawna D Nesbitt; Stevo Julius
Prehypertension: should we be treating with pharmacologic therapy?
Therapeutic advances in cardiovascular disease 2008;2(4):305-14.
2008: Paolo Palatini; Gianfranco Parati; Stevo Julius
Office and out of office heart rate measurements: which clinical value?
Journal of hypertension 2008;26(8):1540-5.
2008: Tonje Amb Aksnes; Sverre E Kjeldsen; M Rostrup; O Störset; Tsushung Hua; Stevo Julius
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.
Journal of human hypertension 2008;22(8):520-7.
2008: Peter M Okin; Eva Gerdts; Sverre E Kjeldsen; Stevo Julius; Jonathan Edelman; Björn Dahlöf; Richard B Devereux
Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
Hypertension 2008;52(1):100-6.
2008: Setareh A Williams; Eric L Michelson; Valerie A Cain; Min Yang; Shawna D Nesbitt; Brent M Egan; Stevo Julius
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY).
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(6):436-42.
2008: Franz H Messerli; Sripal Bangalore; Stevo Julius
Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension.
Circulation 2008;117(20):2706-15; discussion 2715.
2008: Suzanne Oparil; N Abate; E Chen; M A Creager; V Galet; G Jia; Stevo Julius; A Lerman; P A Lyle; J Pool; A M Tershakovec
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
Current medical research and opinion 2008;24(4):1101-14.
2008: Tonje Amb Aksnes; Roland E Schmieder; Sverre Erik Kjeldsen; Sajda Ghani; Tsushung Hua; Stevo Julius
Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial).
The American journal of cardiology 2008;101(5):634-8.
2008: Roland E Schmieder; Sverre E Kjeldsen; Stevo Julius; Gordon T McInnes; Alberto Zanchetti; Tsushung Hua
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
Journal of hypertension 2008;26(3):403-11.
2008: Peter M Okin; Kristian Wachtell; Richard B Devereux; Markku S Nieminen; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Sverre E Kjeldsen; Stevo Julius; Björn Dahlöf
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
American journal of hypertension 2008;21(3):273-9.
2008: Stevo Julius; Niko A Kaciroti; Brent M Egan; Shawna Nesbitt; Eric L Michelson
TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension.
Journal of the American Society of Hypertension : JASH 2008;2(1):39-43.
2008: Sverre E Kjeldsen; Gordon T McInnes; Giuseppe Mancia; Tsushung Hua; Stevo Julius; Michael A Weber; Antonio Coca; Xavier Girerd; Kenneth A Jamerson; Pierre Larochelle; Thomas Macdonald; Roland E Schmieder; M Anthony Schork; Reuven Viskoper; Jiri Widimsky; Alberto Zanchetti
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial.
Blood pressure 2008;17(3):170-7.
2007: Eigil Fossum; Gilbert W Gleim; Sverre E Kjeldsen; Jorge R Kizer; Stevo Julius; Richard B Devereux; W E Brady; Darcy A Hille; Paulette A Lyle; Björn Dahlöf
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.
Journal of internal medicine 2007;262(4):439-48.
2007: Peter M Okin; Richard B Devereux; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Jonathan Edelman; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
Annals of internal medicine 2007;147(5):311-9.
2007: Tonje Amb Aksnes; Sverre E Kjeldsen; Morten Rostrup; Per Omvik; Tsushung Hua; Stevo Julius
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population.
Hypertension 2007;50(3):467-73.
2007: Stevo Julius
Blood pressure lowering only or more? Has the jury reached its verdict?
The American journal of cardiology 2007;100(3A):32J-37J.
2007: Luis M Ruilope; Alberto Zanchetti; Stevo Julius; Gordon T McInnes; Julian Segura; Pelle Stolt; Tsushung Hua; Michael A Weber; Kenneth A Jamerson
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
Journal of hypertension 2007;25(7):1473-9.
2007: Stevo Julius
Should the results of TROPHY affect the JNC 7 definition of prehypertension?
Current hypertension reports 2007;9(3):202-5.
2007: Giuseppe Mancia; Pascal Bousquet; Jean-Luc Elghozi; Murray Esler; Guido Grassi; Stevo Julius; John Reid; Peter A Van Zwieten
The sympathetic nervous system and the metabolic syndrome.
Journal of hypertension 2007;25(5):909-20.
2007: Stevo Julius; Anthony Schork; Brent M Egan
From TROPHY with pride.
American journal of hypertension 2007;20(3):342-3; author reply 343-5.
2007: Ole Lederballe Pedersen; Giuseppe Mancia; Thomas Pickering; Asbjørn Høegholm; Stevo Julius; Sverre E Kjeldsen; Eric S Nielsen; Jens Refsgaard; Michael Weber
Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy.
Journal of hypertension 2007;25(3):707-12.
2006: Alberto Zanchetti; Stevo Julius; Sverre E Kjeldsen; Gordon T McInnes; Tsushung Hua; Michael Weber; John H Laragh; Francis Plat; Edouard Battegay; Cesar Calvo-Vargas; Andrzej Cieśliński; Jean-Paul Degaute; Nicolaas J Holwerda; Janna Kobalava; Ole Lederballe Pedersen; Faustinus P Rudyatmoko; Kostas Siamopoulos; Oyvind Störset
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
Journal of hypertension 2006;24(11):2163-8.
2006: Franz H Messerli; Sripal Bangalore; Brent M Egan; Stevo Julius
Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
The American journal of cardiology 2006;98(8):1122.
2006: Peter M Okin; Kristian Wachtell; Richard B Devereux; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Lars H Lindholm; Markku S Nieminen; Jonathan Edelman; Darcy A Hille; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
JAMA : the journal of the American Medical Association 2006;296(10):1242-8.
2006: Stevo Julius; Michael A Weber; Sverre E Kjeldsen; Gordon T McInnes; Alberto Zanchetti; Hans R Brunner; John H Laragh; M Anthony Schork; Tsushung Hua; John Amerena; Ivan Balazovjech; Graham Cassel; Bela Herczeg; Nevrez Koylan; Dieter Magometschnigg; Silja Majahalme; Felipe Martinez; Willie Oigman; Ricardo Seabra-Gomes; Jun-ren Zhu
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.
Hypertension 2006;48(3):385-91.
2006: Sverre E Kjeldsen; Arne Strand; Stevo Julius; Peter M Okin
Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(7):487-92.
2006: Sverre E Kjeldsen; Stevo Julius; Giuseppe Mancia; Gordon T McInnes; Tsushung Hua; Michael A Weber; Antonio Coca; Steffan Ekman; Xavier Girerd; Kenneth A Jamerson; Pierre Larochelle; Thomas M MacDonald; Roland E Schmieder; M Anthony Schork; Pelle Stolt; Reuven Viskoper; Jiri Widimský; Alberto Zanchetti
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.
Journal of hypertension 2006;24(7):1405-12.
2006: Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko A Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Feasibility of treating prehypertension with an angiotensin-receptor blocker.
The New England journal of medicine 2006;354(16):1685-97.
2006: Paolo Palatini; ATHANASE BENETOS; Guido Grassi; Stevo Julius; Sverre E Kjeldsen; Giuseppe Mancia; Krzystof Narkiewicz; Gianfranco Parati; Achille C Pessina; Luis M Ruilope; Alberto Zanchetti
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting.
Journal of hypertension 2006;24(4):603-10.
2006: Peter M Okin; Richard B Devereux; Eva Gerdts; Steven M Snapinn; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Jonathan Edelman; Lars H Lindholm; Björn Dahlöf
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Circulation 2006;113(12):1588-96.
2006: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Sverre E Kjeldsen; Hans Ibsen; Ying Wan; Stevo Julius
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(3):169-73.
2006: Paolo Palatini; ATHANASE BENETOS; Stevo Julius
Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.
Drugs 2006;66(2):133-44.
2005: Eigil Fossum; andreas moan; Sverre E Kjeldsen; Richard B Devereux; Stevo Julius; Steven M Snapinn; Jonathan Edelman; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Björn Dahlöf
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;46(5):770-5.
2005: Shawna D Nesbitt; Stevo Julius; David Leonard; Brent M Egan; Melissa Grozinski
Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study.
American journal of hypertension 2005;18(7):980-5.
2005: Giovanni de Simone; Kristian Wachtell; Vittorio Palmieri; Darcy A Hille; Gareth Beevers; Björn Dahlöf; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Richard B Devereux
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
Circulation 2005;111(15):1924-31.
2005: Frej Fyhrquist; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Darcy A Hille; Paulette A Lyle; Jonathan Edelman; Steven M Snapinn; Hans Wedel
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
Hypertension 2005;45(4):580-5.
2005: Michael H Olsen; Eigil Fossum; Aud Høieggen; Kristian Wachtell; Elsa Hjerkinn; Shawna D Nesbitt; Ulrik B Andersen; Robert A Phillips; Cynthia L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy.
Journal of hypertension 2005;23(4):891-8.
2005: Sverre E Kjeldsen; Paulette A Lyle; Jorge R Kizer; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Katherine E Harris; Hans Wedel
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(3):152-8.
2005: Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Richard B Devereux
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):712-9.
2005: Kristian Wachtell; Björn Hornestam; Mika Lehto; David Slotwiner; Eva Gerdts; Michael H Olsen; Peter Aurup; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Jens Rokkedal; Richard B Devereux
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):705-11.
2005: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hypertension 2005;45(2):198-202.
2005: Brent M Egan; Vasilios Papademetriou; Marion Wofford; David Calhoun; Jyotika K. Fernandes; Jessica E Riehle; Shawna D Nesbitt; Eric L Michelson; Stevo Julius
Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
American journal of hypertension 2005;18(1):3-12.
2005: Jorge R Kizer; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Kristian Wachtell; Jonathan Edelman; Steven M Snapinn; Katherine E Harris; Richard B Devereux
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
Hypertension 2005;45(1):46-52.
2004: Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven M Snapinn; Katherine E Harris; Peter Aurup; Jonathan Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
JAMA : the journal of the American Medical Association 2004;292(19):2343-9.
2004: Sverre E Kjeldsen; Stevo Julius
Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
American heart journal 2004;148(5):747-54.
2004: Paolo Palatini; Stevo Julius
Elevated heart rate: a major risk factor for cardiovascular disease.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2004;26(7-8):637-44.
2004: Mariaconsuelo Valentini; Stevo Julius; Paolo Palatini; Robert D Brook; Robert L Bard; John D Bisognano; Niko A Kaciroti
Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension.
Journal of hypertension 2004;22(10):1999-2006.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
Journal of hypertension 2004;22(9):1805-11.
2004: Stevo Julius; Shawna D Nesbitt; Brent M Egan; Niko A Kaciroti; M Anthony Schork; Melissa Grozinski; Eric L Michelson
Trial of preventing hypertension: design and 2-year progress report.
Hypertension 2004;44(2):146-51.
2004: Peter M Okin; Richard B Devereux; Markku S Nieminen; Sverker Jern; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Sverre E Kjeldsen; Stevo Julius; Steven M Snapinn; Björn Dahlöf
Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients.
Hypertension 2004;44(1):48-54.
2004: Michael A Weber; Stevo Julius; Sverre E Kjeldsen; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John H Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; M Anthony Schork; Beverly Smith; Alberto Zanchetti
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.
Lancet 2004;363(9426):2049-51.
2004: Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John H Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony M Schork; Beverly Smith; Alberto Zanchetti
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Lancet 2004;363(9426):2022-31.
2004: Henrik M Reims; Sverre E Kjeldsen; W E Brady; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):381-9.
2004: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen
Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy.
Journal of human hypertension 2004;18(6):375-80.
2004: Peter M Okin; Richard B Devereux; Jennifer E Liu; Lasse Oikarinen; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Kristian Wachtell; Markku S Nieminen; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
Journal of human hypertension 2004;18(6):403-9.
2004: Stevo Julius; Michael H Alderman; Gareth Beevers; Björn Dahlöf; Richard B Devereux; Janice G Douglas; Jonathan Edelman; Katherine E Harris; Sverre E Kjeldsen; Shawna D Nesbitt; Otelio S Randall; Jackson T Wright
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.
Journal of the American College of Cardiology 2004;43(6):1047-55.
2004: Aud Høieggen; Michael H Alderman; Sverre E Kjeldsen; Stevo Julius; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Cong Chen; Björn Dahlöf
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Kidney international 2004;65(3):1041-9.
2004: Jay N Cohn; Stevo Julius; Joel M Neutel; Michael Weber; Prasad Turlapaty; Yannan Shen; Victor M Dong; Alicia Batchelor; Weinong Guo; Lagast Hjalmar
Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial.
American journal of hypertension 2004;17(2):134-8.
2004: Henrik M Reims; Suzanne Oparil; Sverre E Kjeldsen; Richard B Devereux; Stevo Julius; William E Brady; Frej Fyhrquist; Hans Ibsen; Lars H Lindholm; Per Omvik; Hans Wedel; Gareth Beevers; Ulf de Faire; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Björn Dahlöf
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
Blood pressure 2004;13(6):376-84.
2004: Joel M Neutel; Michael A Weber; Stevo Julius; Jay N Cohn; Prasad Turlapaty; Yannan Shen; Weinong Guo; Alicia Batchelor; Lagast Hjalmar
Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trial.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2004;4(5):335-41.
2004: Stevo Julius; Jay N Cohn; Joel M Neutel; Michael Weber; Prasad Turlapaty; Yannan Shen; Victor M Dong; Alicia Batchelor; Lagast Hjalmar
Antihypertensive utility of perindopril in a large, general practice-based clinical trial.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(1):10-7.
2003: Kristian Wachtell; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Peter M Okin; Per Omvik; Suzanne Oparil; Hans Wedel; Steven M Snapinn; Peter Aurup
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Annals of internal medicine 2003;139(11):901-6.
2003: Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven M Snapinn; Katherine E Harris; Peter Aurup; Jonathan Edelman; Bjorn Dahlof
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Circulation 2003;108(6):684-90.
2003: Richard B Devereux; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Peter Aurup; Gareth Beevers; Jonathan Edelman; Ulf de Faire; Frej Fyhrquist; Sigrid Helle Berg; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Hans Wedel
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
Annals of internal medicine 2003;139(3):169-77.
2003: Stevo Julius; Sverre E Kjeldsen; Hans Brunner; Lennart Hansson; Francis Platt; Steffan Ekman; John H Laragh; Gordon T McInnes; Anthony M Schork; Beverly Smith; Michael Weber; Alberto Zanchetti
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk.
American journal of hypertension 2003;16(7):544-8.
2003: Michael H Olsen; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Jonathan Bella; Shawna D Nesbitt; Eigil Fossum; Sverre E Kjeldsen; Stevo Julius; Hans Ibsen
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy.
Journal of human hypertension 2003;17(5):305-11.
2003: Alberto Zanchetti; Lennart Hansson; Denis Clement; Dag Elmfeldt; Stevo Julius; Telma Rosenthal; Bernard Waeber; Hans Wedel
Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?
Journal of hypertension 2003;21(4):797-804.
2003: Stevo Julius
Of rat and man.
Journal of hypertension 2003;21(4):705-6.
2003: Stevo Julius
The ALLHAT study: if you believe in evidence-based medicine, stick to it!
Journal of hypertension 2003;21(3):453-4.
2002: Alberto Zanchetti; Lennart Hansson; Björn Dahlöf; Stevo Julius; Joël Ménard; Ingrid Warnold; Hans Wedel
Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk.
Journal of hypertension 2002;20(11):2301-7.
2002: Sverre E Kjeldsen; Björn Dahlöf; Richard B Devereux; Stevo Julius; Peter Aurup; Jonathan Edelman; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Hans Wedel
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
JAMA : the journal of the American Medical Association 2002;288(12):1491-8.
2002: Lars H Lindholm; Hans Ibsen; Knut Borch-Johnsen; Michael H Olsen; Kristian Wachtell; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2002;20(9):1879-86.
2002: Peter M Okin; Jackson T Wright; Markku S Nieminen; Sverker Jern; Anne L Taylor; Robert Phillips; Vasilios Papademetriou; Luther Clark; Elizabeth Ofili; Otelio S Randall; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Stevo Julius; Björn Dahlöf; Richard B Devereux
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
American journal of hypertension 2002;15(8):663-71.
2002: Paolo Palatini; John Amerena; Shawna D Nesbitt; M Valentini; Silja Majahalme; lisa krause; Valérie Tikhonoff; Stevo Julius
Heritability of left atrial size in the Tecumseh population.
European journal of clinical investigation 2002;32(7):467-71.
2002: Karin Skov; Stevo Julius; Shawna Nesbitt; Michael J Mulvany
Can hypertension be prevented? The Danish Hypertension Prevention Project and the Trial of Prevention of Hypertension studies.
Current opinion in cardiology 2002;17(4):380-4.
2002: Pieter A van Zwieten; Stevo Julius
AT1 blockers: are there alternative pathways reducing cardiovascular risk? Introduction.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2002;20(5):S1.
2002: Stevo Julius
The association of tachycardia with obesity and elevated blood pressure.
The Journal of pediatrics 2002;140(6):643-5.
2002: Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):1004-10.
2002: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):995-1003.
2002: Stevo Julius; Silja Majahalme; Shawna D Nesbitt; Eric Grant; Niko A Kaciroti; Hernando Ombao; Olga Vriz; Maria Consuelo Valentini; John Amerena; Lillian Gleiberman
A "gender blind" relationship of lean body mass and blood pressure in the Tecumseh study.
American journal of hypertension 2002;15(3):258-63.
2002: Gianfranco Parati; Peter de Leeuw; Miklos Illyes; Stevo Julius; Iwao Kuwajima; Jean-Michel Mallion; Kuniaki Ohtsuka; Yutaka Imai
Blood pressure measurement in research.
Blood pressure monitoring 2002;7(1):83-7.
2001: Stevo Julius; Silja Majahalme; Paolo Palatini
Antihypertensive treatment of patients with diabetes and hypertension.
American journal of hypertension 2001;14(11 Pt 2):310S-316S.
2001: Peter M Okin; Richard B Devereux; Markku S Nieminen; Sverker Jern; Lasse Oikarinen; Matti Viitasalo; L Toivonen; Sverre E Kjeldsen; Stevo Julius; B Dahlöf
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point.
Journal of the American College of Cardiology 2001;38(2):514-20.
2001: Peter M Okin; Richard B Devereux; Sverker Jern; Stevo Julius; S E Kjeldsen; Björn Dahlöf
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
American journal of hypertension 2001;14(8 Pt 1):775-82.
2001: Paolo Palatini; lisa krause; John Amerena; Shawna D Nesbitt; Silja Majahalme; Valérie Tikhonoff; M Valentini; Stevo Julius
Genetic contribution to the variance in left ventricular mass: the Tecumseh Offspring Study.
Journal of hypertension 2001;19(7):1217-22.
2001: Henrik M Reims; Eigil Fossum; Sverre E Kjeldsen; Stevo Julius
Home blood pressure monitoring. Current knowledge and directions for future research.
Blood pressure 2001;10(5-6):271-87.
2001: Sverre E Kjeldsen; Stevo Julius; Thomas Hedner; Lennart Hansson
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.
Blood pressure 2001;10(4):190-2.
2001: Sverre E Kjeldsen; Stevo Julius; H Brunner; Lennart Hansson; M Henis; S Ekman; John H Laragh; G McInnes; B Smith; M Weber; Alberto Zanchetti
Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation.
Blood pressure 2001;10(2):83-91.
2000: Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Björn Dahlöf
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Hypertension 2000;36(5):766-73.
2000: Shawna D Nesbitt; Stevo Julius
Prehypertension: a possible target for antihypertensive medication.
Current hypertension reports 2000;2(4):356-61.
2000: Sverre E Kjeldsen; Björn Dahlöf; R B Devereux; Stevo Julius; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
American journal of hypertension 2000;13(8):899-906.
2000: Stevo Julius
Five decades of antihypertensive treatment: the unresolved issues.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2000;18(3):S3-7.
2000: Stevo Julius; Silja Majahalme
The changing face of sympathetic overactivity in hypertension.
Annals of medicine 2000;32(5):365-70.
2000: Robert D Brook; Stevo Julius
Autonomic imbalance, hypertension, and cardiovascular risk.
American journal of hypertension 2000;13(6 Pt 2):112S-122S.
2000: Paolo Palatini; Silja Majahalme; John Amerena; Shawna D Nesbitt; Olga Vriz; M Michieletto; lisa krause; Stevo Julius
Determinants of left ventricular structure and mass in young subjects with sympathetic over-activity. The Tecumseh Offspring Study.
Journal of hypertension 2000;18(6):769-75.
2000: SA Yarows; Stevo Julius; T G Pickering
Home blood pressure monitoring.
Archives of internal medicine 2000;160(9):1251-7.
2000: Stevo Julius
Worldwide trends and shortcomings in the treatment of hypertension.
American journal of hypertension 2000;13(5 Pt 2):57S-61S.
2000: Stevo Julius
New clinical trials of angiotensin blockade in cardiovascular disease: foreword.
American journal of hypertension 2000;13(5 Pt 2):55S-56S.
2000: Stevo Julius; Mariaconsuelo Valentini; Paolo Palatini
Overweight and hypertension : a 2-way street?
Hypertension 2000;35(3):807-13.
2000: Michael H Olsen; Eigil Fossum; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Shawna D Nesbitt; Ulrik B Andersen; R A Phillips; C L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia.
Journal of hypertension 2000;18(1):75-81.
2000: Stevo Julius
Trials of antihypertensive treatment--new agenda for the millennium.
American journal of hypertension 2000;13(1 Pt 2):11S-17S.
1999: Pieter A van Zwieten; Stevo Julius
The importance of the sympathetic nervous system in hypertension. Introduction.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1999;17(3):S1.
1999: Stevo Julius
Borderline hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1999;21(5-6):741-7.
1999: Paolo Palatini; Stevo Julius
Relevance of heart rate as a risk factor in hypertension.
Current hypertension reports 1999;1(3):219-24.
1999: Lutgarde Thijs; Jan A Staessen; Hilde Celis; Robert Fagard; P De Cort; Regis De Gaudemaris; I Enström; Yutaka Imai; Stevo Julius; J Ménard; decio mion; Paolo Palatini; Joseph Rosenfeld; D Shapiro; D Spence; G Stergiou
The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects.
Blood pressure monitoring 1999;4(2):77-86.
1999: Paolo Palatini; Edoardo Casiglia; Stevo Julius; Achille C Pessina
High heart rate: a risk factor for cardiovascular death in elderly men.
Archives of internal medicine 1999;159(6):585-92.
1999: Paolo Palatini; Olga Vriz; Shawna D Nesbitt; John Amerena; Silja Majahalme; M Valentini; Stevo Julius
Parental hyperdynamic circulation predicts insulin resistance in offspring: The Tecumseh Offspring Study.
Hypertension 1999;33(3):769-74.
1999: Stevo Julius
Long-term potential of angiotensin receptor blockade for cardiovascular protection in hypertension: the VALUE trial. Valsartan Antihypertensive Long-term Use Evaluation.
Cardiology 1999;91 Suppl 1():8-13.
1999: Paolo Palatini; Stevo Julius
The physiological determinants and risk correlations of elevated heart rate.
American journal of hypertension 1999;12(1 Pt 2):3S-8S.
1998: M A Weber; Stevo Julius
The challenge of very mild hypertension: should treatment be sooner or later?
American journal of hypertension 1998;11(12):1495-6.
1998: Elizabeth A Young; Randolph M Nesse; Alan B Weder; Stevo Julius
Anxiety and cardiovascular reactivity in the Tecumseh population.
Journal of hypertension 1998;16(12 Pt 1):1727-33.
1998: Björn Dahlöf; Richard B Devereux; Stevo Julius; Sverre E Kjeldsen; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Hypertension 1998;32(6):989-97.
1998: Lennart Hansson; Alberto Zanchetti; S G Carruthers; Björn Dahlöf; Dag Elmfeldt; Stevo Julius; J Ménard; K H Rahn; Hans Wedel; S Westerling
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
Lancet 1998;351(9118):1755-62.
1998: Stevo Julius
Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
European heart journal 1998;19 Suppl F():F14-8.
1998: J Mann; Stevo Julius
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
Blood pressure 1998;7(3):176-83.
1998: S E Kjeldsen; T Hedner; Kenneth A Jamerson; Stevo Julius; W E Haley; Miguel Zabalgoitia; A R Butt; SN Rahman; L Hansson
Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects.
Hypertension 1998;31(4):1014-20.
1998: Lutgarde Thijs; Jan A Staessen; Hilde Celis; Regis De Gaudemaris; Y Imai; Stevo Julius; Robert Fagard
Reference values for self-recorded blood pressure: a meta-analysis of summary data.
Archives of internal medicine 1998;158(5):481-8.
1998: Stevo Julius; M Valentini
Consequences of the increased autonomic nervous drive in hypertension, heart failure and diabetes.
Blood pressure. Supplement 1998;3():5-13.
1998: James V Neel; Alan B Weder; Stevo Julius
Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century.
Perspectives in biology and medicine 1998;42(1):44-74.
1998: Stevo Julius; Shawna D Nesbitt
Clinical consequences of the autonomic imbalance in hypertension and congestive heart failure.
Scandinavian cardiovascular journal. Supplement 1998;47():23-30.
1998: Stevo Julius; Paolo Palatini; S D Nesbitt
Tachycardia: an important determinant of coronary risk in hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1998;16(1):S9-15.
1998: James V Neel; Stevo Julius; Alan B Weder; M Yamada; Sharon L R Kardia; MB Haviland
Syndrome X: is it for real?
Genetic epidemiology 1998;15(1):19-32.
1997: Stevo Julius
Current trends in the treatment of hypertension: a mixed picture.
American journal of hypertension 1997;10(12 Pt 2):300S-305S.
1997: Shawna D Nesbitt; John Amerena; Eric Grant; Kenneth A Jamerson; H Lu; Alan B Weder; Stevo Julius
Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study.
American journal of hypertension 1997;10(11):1270-80.
1997: Paolo Palatini; Edoardo Casiglia; Paolo Pauletto; Jan A Staessen; Niko A Kaciroti; Stevo Julius
Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations.
Hypertension 1997;30(5):1267-73.
1997: P Palatini; Stevo Julius; S Collatina; S Rappelli; J Staessen; Achille C Pessina
Optimizing the assessment of the elderly patient with borderline hypertension: the Hypertension and Ambulatory Recording in the OLD (HAROLD) study.
Aging (Milan, Italy) 1997;9(5):365-71.
1997: John Amerena; Shawna D Nesbitt; lisa krause; Eric Grant; H Lu; Stevo Julius
Trends in left ventricular function over three years in the Tecumseh Study.
Blood pressure 1997;6(5):262-8.
1997: Paolo Palatini; Stevo Julius
Association of tachycardia with morbidity and mortality: pathophysiological considerations.
Journal of human hypertension 1997;11 Suppl 1():S19-27.
1997: Björn Dahlöf; R Devereux; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
American journal of hypertension 1997;10(7 Pt 1):705-13.
1997: Stevo Julius
Coronary disease in hypertension: a new mosaic.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(2):S3-10.
1997: Olga Vriz; Shawna D Nesbitt; lisa krause; Silja Majahalme; H Lu; Stevo Julius
Smoking is associated with higher cardiovascular risk in young women than in men: the Tecumseh Blood Pressure Study.
Journal of hypertension 1997;15(2):127-34.
1997: Stevo Julius; M Valentini
Continuing on J.P. Henry's path; studies of physiology and pathophysiology of cardiopulmonary receptors in humans.
Acta physiologica Scandinavica. Supplementum 1997;640():122-4.
1997: Paolo Palatini; Stevo Julius
Heart rate and the cardiovascular risk.
Journal of hypertension 1997;15(1):3-17.
1996: Stevo Julius; Shawna D Nesbitt
Sympathetic overactivity in hypertension. A moving target.
American journal of hypertension 1996;9(11):113S-120S.
1996: Stevo Julius
The Hypertension Optimal Treatment (HOT) Study in the United States.
American journal of hypertension 1996;9(8):41S-44S.
1996: Stevo Julius
The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1996;18(3-4):305-21.
1996: Stevo Julius; Shawna D Nesbitt
Sympathetic nervous system as a coronary risk factor in hypertension.
Cardiologia (Rome, Italy) 1996;41(4):309-17.
1996: Kenneth A Jamerson; Shawna D Nesbitt; John Amerena; E Grant; Stevo Julius
Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects.
Hypertension 1996;27(4):854-8.
1996: Sverre E Kjeldsen; andreas moan; J Petrin; Alan B Weder; Stevo Julius
Effects of increased arterial epinephrine on insulin, glucose and phosphate.
Blood pressure 1996;5(1):27-31.
1995: John Amerena; Stevo Julius
The role of the autonomic nervous system in hypertension.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18(2):99-110.
1995: Sverre E Kjeldsen; Alan B Weder; Brent M Egan; Richard Neubig; AJ Zweifler; Stevo Julius
Effect of circulating epinephrine on platelet function and hematocrit.
Hypertension 1995;25(5):1096-105.
1995: Stevo Julius
The defense reaction: a common denominator of coronary risk and blood pressure in neurogenic hypertension?
Clinical and experimental hypertension (New York, N.Y. : 1993) 1995;17(1-2):375-86.
1994: R Marcus; lisa krause; Alan B Weder; A Dominguez-Meja; N J Schork; Stevo Julius
Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study.
Circulation 1994;90(2):928-36.
1994: Kenneth A Jamerson; S D Smith; John Amerena; E Grant; Stevo Julius
Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction.
Hypertension 1994;23(6 Pt 2):1006-11.
1994: T Gudbrandsson; Stevo Julius; Kenneth A Jamerson; S Smith; lisa krause; N Schork
Recreational exercise and cardiovascular status in the rural community of Tecumseh, Michigan.
Blood pressure 1994;3(3):178-84.
1994: Sverre E Kjeldsen; AJ Zweifler; J Petrin; Alan B Weder; Stevo Julius
Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased beta-adrenoreceptor responsiveness.
Blood pressure 1994;3(3):164-71.
1994: Stevo Julius; Kenneth A Jamerson
Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question.
Journal of hypertension 1994;12(5):495-502.
1994: S Smith; Stevo Julius; Kenneth A Jamerson; John Amerena; N Schork
Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan.
Journal of hypertension 1994;12(4):455-62.
1994: Stevo Julius
Abnormalities of autonomic nervous control in human hypertension.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1994;8 Suppl 1():11-20.
1994: B A Kingwell; L Krause; Stevo Julius
The effect of hypertensive episodes and cardiac hypertrophy on the canine cardiac baroreflex.
Clinical and experimental pharmacology & physiology 1994;21(1):31-9.
1993: Stevo Julius
Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension.
Hypertension 1993;21(6 Pt 2):886-93.
1993: A Zanchetti; J P Chalmers; K Arakawa; I Gyarfas; P Hamet; L Hansson; Stevo Julius; S MacMahon; G Mancia; J Ménard
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting.
Blood pressure 1993;2(2):86-100.
1993: Sverre E Kjeldsen; J Petrin; Alan B Weder; Stevo Julius
Contrasting effects of epinephrine on forearm hemodynamics and arterial plasma norepinephrine.
American journal of hypertension 1993;6(5 Pt 1):369-75.
1993: Kenneth A Jamerson; Stevo Julius; T Gudbrandsson; O Andersson; D O Brant
Reflex sympathetic activation induces acute insulin resistance in the human forearm.
Hypertension 1993;21(5):618-23.
1993: Sverre E Kjeldsen; andreas moan; J Petrin; Alan B Weder; AJ Zweifler; Stevo Julius
Evaluation of self-measured home vs. clinic intra-arterial blood pressure.
Blood pressure 1993;2(1):28-34.
1993: Stevo Julius
Insulin, insulin resistance, and blood pressure elevation.
Archives of internal medicine 1993;153(3):290-1.
1992: Stevo Julius
Assessment of autonomic nervous function in human hypertension.
Current opinion in nephrology and hypertension 1992;1(2):299-305.
1992: Kenneth A Jamerson; N Schork; Stevo Julius
Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure. The Tecumseh Blood Pressure Study.
Hypertension 1992;20(3):314-8.
1992: Sverre E Kjeldsen; R K Gupta; lisa krause; Alan B Weder; Stevo Julius
Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
American heart journal 1992;123(5):1433-8.
1992: Stevo Julius; T Gudbrandsson; Kenneth A Jamerson; O Andersson
The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension.
Blood pressure 1992;1(1):9-19.
1992: T Gudbrandsson; Stevo Julius; lisa krause; Kenneth A Jamerson; O S Randall; N Schork; Alan B Weder
Correlates of the estimated arterial compliance in the population of Tecumseh, Michigan.
Blood pressure 1992;1(1):27-34.
1992: Stevo Julius; Kenneth A Jamerson; T Gudbrandsson; N Schork
White coat hypertension: a follow-up.
Clinical and experimental hypertension. Part A, Theory and practice 1992;14(1-2):45-53.
1992: Stevo Julius
Treatment of hypertension.
Blood pressure. Supplement 1992;4():43-7.
1992: Stevo Julius; T Gudbrandsson
Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk.
Journal of cardiovascular pharmacology 1992;20 Suppl 8():S40-8.
1991: Stevo Julius
Home blood pressure monitoring: advantages and limitations.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(3):S41-6.
1991: Kenneth A Jamerson; Stevo Julius
Predictors of blood pressure and hypertension. General principles.
American journal of hypertension 1991;4(11):598S-602S.
1991: Stevo Julius; T Gudbrandsson; Kenneth A Jamerson; S Tariq Shahab; O Andersson
The hemodynamic link between insulin resistance and hypertension.
Journal of hypertension 1991;9(11):983-6.
1991: Stevo Julius
Clinical implications of pathophysiologic changes in the midlife hypertensive patient.
American heart journal 1991;122(3 Pt 2):886-91.
1991: Alan B Weder; N J Schork; Stevo Julius
Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan.
Hypertension 1991;17(6 Pt 2):977-81.
1991: Stevo Julius; Ying Li; D Brant; lisa krause; D Taylor
Quinapril, an angiotensin converting enzyme inhibitor, prevents cardiac hypertrophy during episodic hypertension.
Hypertension 1991;17(6 Pt 2):1161-6.
1991: AJ Buda; Ying Li; D Brant; lisa krause; Stevo Julius
Changes in left ventricular diastolic filling during the development of left ventricular hypertrophy: observations using Doppler echocardiography in a unique canine model.
American heart journal 1991;121(6 Pt 1):1759-67.
1991: Alan B Weder; N J Schork; lisa krause; Stevo Julius
Red blood cell lithium-sodium countertransport in the tecumseh blood pressure study.
Hypertension 1991;17(5):652-60.
1991: Stevo Julius
Autonomic nervous system dysregulation in human hypertension.
The American journal of cardiology 1991;67(10):3B-7B.
1991: Stevo Julius; Kerin A Jones; N Schork; E Johnson; lisa krause; P Nazzaro; A Zemva
Independence of pressure reactivity from pressure levels in Tecumseh, Michigan.
Hypertension 1991;17(4 Suppl):III12-21.
1991: Stevo Julius
Autonomic nervous dysfunction in essential hypertension.
Diabetes care 1991;14(3):249-59.
1991: Stevo Julius; lisa krause; N J Schork; A D Mejia; Kerin A Jones; Cosmas van de Ven; E H Johnson; M A Sekkarie; Sverre E Kjeldsen; J Petrin
Hyperkinetic borderline hypertension in Tecumseh, Michigan.
Journal of hypertension 1991;9(1):77-84.
1991: R K Gupta; Sverre E Kjeldsen; Evangeline D Motley-Johnson; Alan B Weder; AJ Zweifler; Stevo Julius
Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
Journal of cardiovascular pharmacology 1991;17(1):13-9.
1990: Stevo Julius; A Mejia; Kerin A Jones; lisa krause; N Schork; Cosmas van de Ven; E Johnson; J Petrin; M A Sekkarie; Sverre E Kjeldsen
"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.
Hypertension 1990;16(6):617-23.
1990: Stevo Julius
Validation of non-invasive measurement of cardiac output. The Ann Arbor experience.
European heart journal 1990;11 Suppl I():144-7.
1990: Stevo Julius
Changing role of the autonomic nervous system in human hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S59-65.
1990: Stevo Julius; Kenneth A Jamerson; A Mejia; lisa krause; N Schork; Kerin A Jones
The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study.
JAMA : the journal of the American Medical Association 1990;264(3):354-8.
1990: R K Gupta; Sverre E Kjeldsen; lisa krause; J Kneisley; E Posvar; Alan B Weder; Stevo Julius
Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
Clinical pharmacology and therapeutics 1990;48(1):41-9.
1990: A D Mejia; Stevo Julius; Kerin A Jones; N J Schork; J Kneisley
The Tecumseh Blood Pressure Study. Normative data on blood pressure self-determination.
Archives of internal medicine 1990;150(6):1209-13.
1990: N J Schork; Alan B Weder; M A Schork; D R Bassett; Stevo Julius
Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension.
Statistics in medicine 1990;9(3):301-14.
1990: J Kneisley; N Schork; Stevo Julius
Predictors of blood pressure and hypertension in Tecumseh, Michigan.
Clinical and experimental hypertension. Part A, Theory and practice 1990;12(5):693-708.
1990: Stevo Julius
Are different hemodynamic patterns of antihypertensive drugs clinically important?
European journal of clinical pharmacology 1990;38 Suppl 2():S125-8.
1990: Stevo Julius
Hemodynamic and neurohumoral evidence of multifaceted pathophysiology in human hypertension.
Journal of cardiovascular pharmacology 1990;15 Suppl 5():S53-8.
1990: F R Bühler; Stevo Julius; G M Reaven
A new dimension in hypertension: role of insulin resistance.
Journal of cardiovascular pharmacology 1990;15 Suppl 5():S1-3.
1989: J Petrin; Brent M Egan; Stevo Julius
Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S78-9.
1989: Stevo Julius; R Gupta
Angiotensin converting enzyme inhibitors and the progress of antihypertensive therapy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(5):S23-7.
1989: R H Schneider; Stevo Julius; R Karunas
Ambulatory blood pressure monitoring and laboratory reactivity in type A behavior and components.
Psychosomatic medicine 1989;51(3):290-305.
1989: A Mejia; Stevo Julius
Practical utility of blood pressure readings obtained by self-determination.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(3):S53-7.
1989: Stevo Julius; Ying Li; D Brant; lisa krause; AJ Buda
Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy.
Hypertension 1989;13(5):422-9.
1989: Alan B Weder; M Takiyyuddin; M A Sekkarie; Stevo Julius
Behaviour and hypertension: a pathophysiological puzzle.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(1):S13-7.
1989: Stevo Julius; Alan B Weder
Brain and the regulation of blood pressure: a hemodynamic perspective.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11 Suppl 1():1-19.
1988: M P Sambhi; A V Chobanian; Stevo Julius; R H Noth; N O Borhani; H M Perry
University of California, Davis, conference: Mild hypertension.
The American journal of medicine 1988;85(5):675-96.
1988: Stevo Julius
Interaction between renin and the autonomic nervous system in hypertension.
American heart journal 1988;116(2 Pt 2):611-6.
1988: Stevo Julius
Transition from high cardiac output to elevated vascular resistance in hypertension.
American heart journal 1988;116(2 Pt 2):600-6.
1988: Brent M Egan; M E Conlon; R Campbell; N Schork; A Zwiefler; Stevo Julius
Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension.
American journal of hypertension 1988;1(3 Pt 3):324S-330S.
1988: Stevo Julius
The blood pressure seeking properties of the central nervous system.
Journal of hypertension 1988;6(3):177-85.
1988: Stevo Julius; D Brant
Hemodynamic plasticity during hindquarter compression.
Acta physiologica Scandinavica. Supplementum 1988;571():107-16.
1988: Stevo Julius
The therapeutic dilemma of hypertension in the elderly.
Drugs 1988;36 Suppl 1():7-17.
1988: Stevo Julius
Amlodipine in hypertension: an overview of the clinical dossier.
Journal of cardiovascular pharmacology 1988;12 Suppl 7():S27-33.
1988: Stevo Julius; N Schork; Anthony M Schork
Sympathetic hyperactivity in early stages of hypertension: the Ann Arbor data set.
Journal of cardiovascular pharmacology 1988;12 Suppl 3():S121-9.
1987: Alan B Weder; M A Sekkarie; M Takiyyuddin; N J Schork; Stevo Julius
Antihypertensive and hypotensive effects of atrial natriuretic factor in men.
Hypertension 1987;10(6):582-9.
1987: R H Schneider; Stevo Julius; G E Moss; T E Dielman; AJ Zweifler; R Karunas
New markers for type A behavior: pupil size and platelet epinephrine.
Psychosomatic medicine 1987;49(6):579-90.
1987: Brent M Egan; R Panis; Alan L Hinderliter; N Schork; Stevo Julius
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.
The Journal of clinical investigation 1987;80(3):812-7.
1987: Stevo Julius
Role of the sympathetic nervous system in the pathophysiology of cardiovascular disease.
American heart journal 1987;114(1 Pt 2):232-4.
1987: A P Shapiro; Michael H Alderman; T B Clarkson; Curt D Furberg; M J Jesse; Stevo Julius; R E Miller; Bertram Pitt
Behavioral consequences of hypertension and antihypertensive therapy.
Circulation 1987;76(1 Pt 2):I101-3.
1987: D P Zipes; M N Levy; L A Cobb; Stevo Julius; P G Kaufman; N E Miller; R L Verrier
Sudden cardiac death. Neural-cardiac interactions.
Circulation 1987;76(1 Pt 2):I202-7.
1987: Alan B Weder; M A Fitzpatrick; B A Torretti; Alan L Hinderliter; Brent M Egan; Stevo Julius
Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension.
Hypertension 1987;9(5):459-66.
1987: R A Sanchez; E J Marco; C Oliveri; F J Otero; O Degrossi; L I Moledo; Stevo Julius
Role of cardiopulmonary mechanoreceptors in the postural regulation of renin.
The American journal of cardiology 1987;59(8):881-6.
1987: Alan L Hinderliter; M A Fitzpatrick; N Schork; Stevo Julius
Research utility of noninvasive methods for measurement of cardiac output.
Clinical pharmacology and therapeutics 1987;41(4):419-25.
1987: Brent M Egan; M A Fitzpatrick; Stevo Julius
The heart and the regulation of renin.
Circulation 1987;75(1 Pt 2):I130-3.
1987: Stevo Julius
Discussion on the search for an ideal vasodilator: a hemodynamic perspective.
Journal of cardiovascular pharmacology 1987;10 Suppl 1():S149-53.
1986: M A Fitzpatrick; Alan L Hinderliter; Brent M Egan; Stevo Julius
Decreased venous distensibility and reduced renin responsiveness in hypertension.
Hypertension 1986;8(6 Pt 2):II36-43.
1986: R H Schneider; Brent M Egan; E H Johnson; H Drobny; Stevo Julius
Anger and anxiety in borderline hypertension.
Psychosomatic medicine 1986;48(3-4):242-8.
1986: Stevo Julius
The emerging field of borderline hypertension.
Journal of cardiovascular pharmacology 1986;8 Suppl 5():S4-7.
1985: Stevo Julius; E H Johnson
Stress, autonomic hyperactivity and essential hypertension: an enigma.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(4):S11-7.
1985: Brent M Egan; Richard Neubig; Stevo Julius
Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number.
Clinical pharmacology and therapeutics 1985;38(5):519-24.
1985: Alan B Weder; Stevo Julius
Behavior, blood pressure variability, and hypertension.
Psychosomatic medicine 1985;47(5):406-14.
1985: Brent M Egan; Stevo Julius
Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive.
Clinical and experimental hypertension. Part A, Theory and practice 1985;7(2-3):243-55.
1985: M A Fitzpatrick; Stevo Julius
Hemodynamic effects of angiotensin-converting enzyme inhibitors in essential hypertension: a review.
Journal of cardiovascular pharmacology 1985;7 Suppl 1():S35-9.
1985: Brent M Egan; Richard Neubig; Robert H Schneider; Stevo Julius
Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans.
Journal of cardiovascular pharmacology 1985;7 Suppl 6():S153-8.
1984: J J Ferguson; Stevo Julius; O S Randall
Stroke volume--pulse pressure relationships in borderline hypertension: a possible indicator of decreased arterial compliance.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1984;2(3):S397-9.
1984: Brent M Egan; Roger J Grekin; H Ibsen; K Osterziel; Stevo Julius
Role of cardiopulmonary mechanoreceptors in ADH release in normal humans.
Hypertension 1984;6(6 Pt 1):832-6.
1984: C Cottier; K Shapiro; Stevo Julius
Treatment of mild hypertension with progressive muscle relaxation. Predictive value of indexes of sympathetic tone.
Archives of internal medicine 1984;144(10):1954-8.
1984: K J Osterziel; Stevo Julius; D O Brant
Blood pressure elevation during hindquarter compression in dogs is neurogenic.
Journal of hypertension 1984;2(4):411-7.
1984: H T Colfer; C Cottier; R Sanchez; Stevo Julius
Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.
Hypertension 1984;6(2 Pt 1):145-51.
1984: Alan B Weder; B A Torretti; Stevo Julius
Racial differences in erythrocyte cation transport.
Hypertension 1984;6(1):115-23.
1984: H Ibsen; Stevo Julius
Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
Federation proceedings 1984;43(1):67-71.
1983: Brent M Egan; Stevo Julius; C Cottier; K J Osterziel; H Ibsen
Role of cardiovascular receptors on the neural regulation of renin release in normal men.
Hypertension 1983;5(5):779-86.
1983: Stevo Julius; C Cottier; Brent M Egan; H Ibsen; W Kiowski
Cardiopulmonary mechanoreceptors and renin release in humans.
Federation proceedings 1983;42(10):2703-8.
1983: Brent M Egan; Stevo Julius
Borderline hypertension.
Primary care 1983;10(1):99-113.
1983: H Ibsen; Brent M Egan; K Osterziel; A Vander; Stevo Julius
Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans.
Hypertension 1983;5(2 Pt 2):I184-91.
1983: C Cottier; Stevo Julius
Use of clonidine and propranolol as monotherapy in borderline hypertension.
Chest 1983;83(2 Suppl):422-5.
1982: Stevo Julius; R Sanchez; S Malayan; M Hamlin; M Elkins; D Brant; D F Bohr
Sustained blood pressure elevation to lower body compression in pigs and dogs.
Hypertension 1982;4(6):782-8.
1982: K J Osterziel; Stevo Julius
Vasodilators in the treatment of hypertension.
Comprehensive therapy 1982;8(11):43-52.
1982: C Cottier; Stevo Julius; S V Gajendragadkar; M A Schork
Usefulness of home BP determination in treating borderline hypertension.
JAMA : the journal of the American Medical Association 1982;248(5):555-8.
1982: AJ Zweifler; Stevo Julius
Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines.
The New England journal of medicine 1982;306(15):890-4.
1982: W Victery; A J Vander; J M Shulak; P Schoeps; Stevo Julius
Lead, hypertension, and the renin-angiotensin system in rats.
The Journal of laboratory and clinical medicine 1982;99(3):354-62.
1981: M G Nicholls; E A Espiner; K D Miles; AJ Zweifler; Stevo Julius
Evidence against an interaction of angiotensin II with the sympathetic nervous system in man.
Clinical endocrinology 1981;15(5):423-30.
1981: W Kiowski; O S Randall; T G Steffens; Stevo Julius
Reliability of echocardiography in assessing cardiac output. A comparative study with a dye dilution technique.
Klinische Wochenschrift 1981;59(19):1115-20.
1981: M G Nicholls; Stevo Julius; AJ Zweifler
Withdrawal of endogenous sympathetic drive lowers blood pressure in primary aldosteronism.
Clinical endocrinology 1981;15(3):253-8.
1981: AJ Zweifler; Stevo Julius; M G Nicholls
Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
Archives of internal medicine 1981;141(7):907-10.
1981: Stevo Julius
The psychophysiology of borderline hypertension.
Research publications - Association for Research in Nervous and Mental Disease 1981;59():293-303.
1980: Stevo Julius
Practical management of borderline hypertension.
Comprehensive therapy 1980;6(3):43-8.
1980: Stevo Julius; L Hansson; L Andrén; T Gudbrandsson; R Sivertsson; A Svensson
Borderline hypertension. Hypertension seminars at Ostra Hospital, Göteberg, Sweden.
Acta medica Scandinavica 1980;208(6):481-9.
1980: M G Nicholls; W Kiowski; AJ Zweifler; Stevo Julius; M A Schork; J Greenhouse
Plasma norepinephrine variations with dietary sodium intake.
Hypertension 1980;2(1):29-32.
1979: A P Shapiro; H Benson; A V Chobanian; J A Herd; Stevo Julius; N Kaplan; R S Lazarus; A M Ostfeld; S L Syme
The role of stress in hypertension.
Journal of human stress 1979;5(2):7-26.
1978: W Kiowski; Stevo Julius
Renin response to stimulation of cardiopulmonary mechanoreceptors in man.
The Journal of clinical investigation 1978;62(3):656-63.
1978: M Esler; AJ Zweifler; O Randall; Stevo Julius; V DeQuattro
The determinants of plasma-renin activity in essential hypertension.
Annals of internal medicine 1978;88(6):746-52.
1978: Stevo Julius; M A Schork
Predictors of hypertension.
Annals of the New York Academy of Sciences 1978;304():38-58.
1978: O Randall; M Esler; B Culp; Stevo Julius; AJ Zweifler
Determinants of baroreflex sensitivity in man.
The Journal of laboratory and clinical medicine 1978;91(3):514-9.
1978: Stevo Julius
Clinical and physiological significance of borderline hypertension at youth.
Pediatric clinics of North America 1978;25(1):35-45.
1978: G Simon; W Kiowski; Stevo Julius
Antihypertensive and beta-adrenoceptor antagonist action of timolol.
Clinical pharmacology and therapeutics 1978;23(2):152-7.
1978: Stevo Julius
Borderline hypertension: significance and management.
Cardiovascular clinics 1978;9(1):31-41.
1978: Stevo Julius
Borderline hypertension: clinical and pathophysiologic significance.
Ergebnisse der inneren Medizin und Kinderheilkunde 1978;41():51-84.
1977: G Simon; W Kiowski; Stevo Julius
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension.
Clinical pharmacology and therapeutics 1977;22(3):293-8.
1977: M Esler; AJ Zweifler; O Randall; Stevo Julius; V DeQuattro
Agreement among three different indices of sympathetic nervous system activity in essential hypertension.
Mayo Clinic proceedings. Mayo Clinic 1977;52(6):379-82.
1977: Stevo Julius
Borderline hypertension. An overview.
The Medical clinics of North America 1977;61(3):495-511.
1977: M Esler; Stevo Julius; AJ Zweifler; O Randall; E Harburg; H Gardiner; V DeQuattro
Mild high-renin essential hypertension. Neurogenic human hypertension?
The New England journal of medicine 1977;296(8):405-11.
1977: Stevo Julius; M Esler
Patterns of neurogenic involvement in borderline and essential hypertension.
Progress in brain research 1977;47():251-62.
1976: Stevo Julius
Abnormalities of autonomic nervous control in borderline hypertension.
Schweizerische medizinische Wochenschrift 1976;106(49):1698-705.
1976: O S Randall; M D Esler; E G Bulloch; A S Maisel; Charles Ellis; AJ Zweifler; Stevo Julius
Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man.
Clinical science and molecular medicine. Supplement 1976;3():357s-360s.
1976: Stevo Julius; M Esler
Increased central blood volume: a poosible pathophysiological factor im mild low-renin essential hypertension.
Clinical science and molecular medicine. Supplement 1976;3():207s-210s.
1976: M Esler; Stevo Julius; O Randall; V DeQuattro; AJ Zweifler
High-renin essential hypertension: adrenergic cardiovascular correlates.
Clinical science and molecular medicine. Supplement 1976;3():181s-184s.
1976: M Esler; O Randall; J Bennett; AJ Zweifler; Stevo Julius; P Rydelek
Suppression of sympathetic nervous function in low-renin essential hypertension.
Lancet 1976;2(7977):115-8.
1976: Stevo Julius; M Esler; L Hansson; A J Zwiefler
Dissociation of the renin lowering and antihypertensive actions of propranolol.
Advances in clinical pharmacology 1976;11():33-41.
1975: M D Esler; Stevo Julius; O S Randall; Charles Ellis; T Kashima
Relation of renin status to neurogenic vascular resistance in borderline hypertension.
The American journal of cardiology 1975;36(5):708-15.
1975: Stevo Julius; M Esler
Autonomic nervous cardiovascular regulation in borderline hypertension.
The American journal of cardiology 1975;36(5):685-96.
1975: Stevo Julius
Letter: Home blood-pressure recording.
Lancet 1975;2(7932):464-5.
1975: I Albrecht; M Hallbäck; Stevo Julius; Y Lundgren; L Stage; L Weiss; B Folkow
Arterial pressure, cardiac output and systemic resistance before and after pithing in normotensive and spontaneously hypertensive rats.
Acta physiologica Scandinavica 1975;94(3):378-85.
1975: Stevo Julius; O S Randall; M D Esler; T Kashima; Charles Ellis; J Bennett
Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension.
Circulation research 1975;36(6 Suppl 1):199-207.
1975: Stevo Julius; M D Esler; O S Randall
Role of the autonomic nervous system in mild human hypertension.
Clinical science and molecular medicine. Supplement 1975;2():243s-252s.
1974: L Hansson; AJ Zweifler; Stevo Julius; Charles Ellis
Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.
International journal of clinical pharmacology, therapy and toxicology 1974;10(2):79-89.
1974: Stevo Julius; Charles Ellis; A V Pascual; M Matice; L Hansson; S N Hunyor; L N Sandler
Home blood pressure determination. Value in borderline ("labile") hypertension.
JAMA : the journal of the American Medical Association 1974;229(6):663-6.
1974: L Hansson; AJ Zweifler; Stevo Julius; S N Hunyor
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.
Acta medica Scandinavica 1974;196(1-2):27-34.
1974: Stevo Julius; M Esler; O S Randall; Charles Ellis
Neurogenic maintenance of peripheral resistance in borderline hypertension.
Acta physiologica latino americana 1974;24(5):425-31.
1974: Stevo Julius; L M Hansson
Hemodynamics of prehypertension and hypertension.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1974;80():49-58.
1973: L Hansson; S N Hunyor; Stevo Julius; S W Hoobler
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management.
American heart journal 1973;85(5):605-10.
1973: Charles Ellis; Stevo Julius
Role of central blood volume in hyperkinetic borderline hypertension.
British heart journal 1973;35(4):450-5.
1973: C B Ernst; L Hansson; S N Hunyor; Stevo Julius
[Stimulation of the sinus nerves with an implanted baropacer in patients with therapy-resistant hypertension].
Läkartidningen 1973;70(12):1166-8.
1973: L Hansson; A Pascual; Stevo Julius
Comparison of guanadrel and guanethidine.
Clinical pharmacology and therapeutics 1973;14(2):204-8.
1972: L Hansson; Stevo Julius; R Sannerstedt
[Latent hypertension].
Läkartidningen 1972;69(36):4011-4.
1972: R Sannerstedt; Stevo Julius
Systemic haemodynamics in borderline arterial hypertension: responses to static exercise before and under the influence of propranolol.
Cardiovascular research 1972;6(4):398-403.
1972: Stevo Julius; A V Pascual; P H Abbrecht; R London
Effect of beta-adrenergic blockade on plasma volume in human subjects.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1972;140(3):982-5.
1971: S Hoobler; Stevo Julius
Questions and answers on hypertension.
Medical times 1971;99(9):92-4 passim.
1971: Stevo Julius; A V Pascual; R London
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension.
Circulation 1971;44(3):413-8.
1971: Stevo Julius; A V Pascual; R Sannerstedt; C Mitchell
Relationship between cardiac output and peripheral resistance in borderline hypertension.
Circulation 1971;43(3):382-90.
1971: Stevo Julius; M A Schork
Borderline hypertension--a critical review.
Journal of chronic diseases 1971;23(10):723-54.
1971: Stevo Julius; A V Pascual; K Reilly; R London
Abnormalities of plasma volume in borderline hypertension.
Archives of internal medicine 1971;127(1):116-9.
1970: R Sannerstedt; Stevo Julius; J Conway
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension.
Circulation 1970;42(6):1057-64.
1968: Stevo Julius; J Conway
Hemodynamic studies in patients with borderline blood pressure elevation.
Circulation 1968;38(2):282-8.
1967: A Amery; Stevo Julius; L S Whitlock; J Conway
Influence of hypertension on the hemodynamic response to exercise.
Circulation 1967;36(2):231-7.
1967: Stevo Julius; A Amery; L S Whitlock; J Conway
Influence of age on the hemodynamic response to exercise.
Circulation 1967;36(2):222-30.
1967: Stevo Julius; B H Stewart
Diagnostic significance of abdominal murmurs.
The New England journal of medicine 1967;276(21):1175-8.
1966: S S Sanbar; F J Conway; AJ Zweifler; Stevo Julius; S W Hoobler
Familial hyperlipoproteinemic syndromes.
University of Michigan Medical Center journal 1966;32(6):277-82.
1965: N F MCGINN; E HARBURG; Stevo Julius
BLOOD PRESSURE REACTIVITY AND RECALL OF TREATMENT BY PARENTS.
Journal of personality and social psychology 1965;95():147-53.
1964: E HARBURG; Stevo Julius; N F MCGINN; J MCLEOD; S W HOOBLER
PERSONALITY TRAITS AND BEHAVIORAL PATTERNS ASSOCIATED WITH SYSTOLIC BLOOD PRESSURE LEVELS IN COLLEGE MALES.
Journal of chronic diseases 1964;17():405-14.
1964: N F MCGINN; E HARBURG; Stevo Julius; J M MCLEOD
PSYCHOLOGICAL CORRELATES OF BLOOD PRESSURE.
Psychological bulletin 1964;61():209-19.
1963: J CONWAY; AJ Zweifler; Stevo Julius
THE PLACE OF METHYLDOPA IN THE TREATMENT OF SEVERE HYPERTENSION.
JAMA : the journal of the American Medical Association 1963;186():266-8.